Verastem, INC Schedule 13G passive stakes

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 7,024,000 shares, representing 7.76% of Verastem, Inc.'s common stock, as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 5.8% of Verastem Inc.'s common stock, holding over 5.1 million shares.

Vanguard Capital Management has reported beneficial ownership of 5.03% of Verastem Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 7.0% of Verastem Inc.'s common stock as of June 30, 2026.

Polar Capital Holdings Plc, Polar Capital LLP, and Polar Capital Funds PLC report a beneficial ownership of 4.80% in Verastem, Inc.

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 5.23% in Verastem, Inc. common stock as of March 31, 2026.

RTW Investments, LP and Roderick Wong have reported beneficial ownership of 9,018,724 shares of Verastem, Inc. common stock, representing 9.9% of the class.

Balyasny Asset Management L.P. and affiliated entities have reported beneficial ownership of 1,360,391 shares of Verastem Inc. common stock, representing 1.55% of the class.

The Vanguard Group has reported 0% beneficial ownership in Verastem Inc. following an internal realignment.

RTW Investments, LP and Roderick Wong, M.D. reported a 9.99% beneficial ownership stake in Verastem, Inc., including exercisable warrants.

Balyasny Asset Management and its affiliates have reported a 6.18% beneficial ownership stake in Verastem Inc., comprising common stock and warrants.

Nantahala Capital Management and its managing members reported a 4.72% beneficial ownership stake in Verastem, Inc. as of December 31, 2025, indicating a reduction from previous filings.

Polar Capital Holdings Plc and its affiliates have reported a 5.09% beneficial ownership stake in Verastem, Inc. as of December 31, 2025.

Deep Track Capital, LP and affiliated entities have reported a 9.99% beneficial ownership stake in Verastem, Inc. common stock.

Nantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, reported a 7.13% beneficial ownership stake in Verastem, Inc. common stock.

Logos Global Management LP and its affiliates have disclosed a 4.8% beneficial ownership stake in Verastem, Inc. common stock.

Balyasny Asset Management and its affiliates reported a 9.29% beneficial ownership stake in Verastem Inc., totaling 5,718,190 shares.

Stonepine Capital Management and its affiliates have filed an amended Schedule 13G, reporting a 4.3% beneficial ownership stake in Verastem, Inc. common stock.

Foresite Capital Fund VI LP, Foresite Capital Management VI, LLC, and James Tananbaum have reported a 5.1% beneficial ownership in Verastem, Inc. common stock.

BlackRock, Inc. has reported a 6.0% beneficial ownership stake in Verastem Inc. common stock, holding 3,676,905 shares.

OrbiMed Advisors LLC has disclosed a 2.4% beneficial ownership stake in Verastem, Inc., holding 1,333,333 warrants to purchase common stock.

RTW Investments, LP and Roderick Wong have disclosed a 9.99% beneficial ownership stake in Verastem, Inc., including warrants.

Balyasny Asset Management and its affiliates report a 9.99% beneficial ownership stake in Verastem Inc., including shares from exercisable warrants.

Biotechnology Value Fund and its affiliates have updated their beneficial ownership in Verastem, Inc., holding an aggregate of 2.5 million shares, representing 3.9% of the company's common stock.

Biotechnology Value Fund and its affiliates reported a combined beneficial ownership of 9.99% in Verastem, Inc. common stock as of June 30, 2025.

Barclays PLC has reported a complete divestment of its beneficial ownership in Verastem Inc, now holding 0% of the common stock.

Stonepine Capital entities and Jon M. Plexico have disclosed a 5.0% beneficial ownership stake in Verastem, Inc., totaling 2,833,333 shares.

AIGH Capital Management LLC and Orin Hirschman have reduced their beneficial ownership in Verastem, Inc. to 3.6% of the common stock, as disclosed in an Amendment No. 1 to their Schedule 13G filing.

The Vanguard Group has reported a passive beneficial ownership of 6.23% in Verastem Inc., totaling 3,423,617 common shares.

Logos Global Management LP and its affiliates have disclosed a 6.2% passive beneficial ownership stake in Verastem, Inc.'s common stock.